Skip to main content
Erschienen in: Annals of Nuclear Medicine 2/2020

25.11.2019 | Original Article

Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study

verfasst von: Yoko Satoh, Utaroh Motosugi, Masamichi Imai, Hiroshi Onishi

Erschienen in: Annals of Nuclear Medicine | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

High-resolution dedicated breast positron emission tomography (dbPET) can visualize breast cancer more clearly than whole-body PET/computed tomography (CT). In Japan, the combined use of dbPET and whole-body PET/CT is necessary in indications for health insurance. Although several clinical studies have compared both devices, a physical evaluation by the phantom test has not been reported. The aim of this study was to compare the ability of ring-shaped dbPET and whole-body PET/CT using a common phantom with reference to the Japanese guideline for the oncology 18F-fluorodeoxyglucose (FDG)-PET/CT data acquisition protocol.

Methods

A cylindrical breast phantom with four spheres of different diameters (16, 10, 7.5, and 5 mm) filled an FDG solution at sphere-to-background radioactivity ratios (SBRs) of 2:1, 4:1, and 8:1 was prepared. Images were then acquired by whole-body PET/CT and subsequently by dbPET. The reconstructed images were visually evaluated and the coefficient of variation and uniformity of the background (CVbackground and SDΔSUVmean), percentages of contrast and background variability (%QH,5mm and %N5mm), and their ratio (%QH,5mm/N5mm), and relative recovery coefficient were compared with the standards defined in the protocol for whole-body PET/CT.

Results

The parameters were calculated at an SBR of 8:1, which was the only SBR in which a 5-mm sphere was visible on both devices. The standards were defined as < 10% for CVbackground, ≤ 0.025 for SDΔSUVmean, < 5.6% for %N5mm, > 2.8 for %QH,5mm/N5mm, and > 0.38 for the relative recovery coefficient of the smallest sphere (10 mm in diameter) in the protocol for whole-body PET/CT (the %QH,5mm was not determined for that protocol); the respective values were 6.14%, 0.024, 4.55%, 3.66, and 0.33 for dbPET and 2.21%, 0.021, 3.11%, 1.72, and 0.18 for PET/CT. The QH,5mm was 16.67% for dbPET and 5.34% for PET/CT. The human images also showed higher lesion-to-background contrast on dbPET than on PET/CT despite the noisier background observed with dbPET.

Conclusion

The common phantom study showed that the background was noisier and that the contrast was much higher in the dbPET image than in the PET/CT image. The acquisition protocol and standards for dbPET will need to be different from those used for whole-body PET/CT.
Literatur
1.
Zurück zum Zitat Groheux D, Espie M, Giacchetti S, Hindie E. Performance of FDG PET/CT in the clinical management of breast cancer. Radiology. 2013;266:388–405.CrossRef Groheux D, Espie M, Giacchetti S, Hindie E. Performance of FDG PET/CT in the clinical management of breast cancer. Radiology. 2013;266:388–405.CrossRef
2.
Zurück zum Zitat Lee SM, Bae SK, Kim TH, Yoon HK, Jung SJ, Park JS, et al. Value of 18F-FDG PET/CT for early prediction of pathologic response (by residual cancer burden criteria) of locally advanced breast cancer to neoadjuvant chemotherapy. Clin Nucl Med. 2014;39:882–6.CrossRef Lee SM, Bae SK, Kim TH, Yoon HK, Jung SJ, Park JS, et al. Value of 18F-FDG PET/CT for early prediction of pathologic response (by residual cancer burden criteria) of locally advanced breast cancer to neoadjuvant chemotherapy. Clin Nucl Med. 2014;39:882–6.CrossRef
3.
Zurück zum Zitat Satoh Y, Nambu A, Ichikawa T, Onishi H. Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer. BMC Cancer. 2014;14:525.CrossRef Satoh Y, Nambu A, Ichikawa T, Onishi H. Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer. BMC Cancer. 2014;14:525.CrossRef
4.
Zurück zum Zitat Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influence of tumor stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ. 2015;351:h4901.CrossRef Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influence of tumor stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ. 2015;351:h4901.CrossRef
5.
Zurück zum Zitat Ichizawa N, Fukutomi T, Iwamoto E, Akashi-Tanaka S. Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification. Jpn J Clin Oncol. 2002;32:108–9.CrossRef Ichizawa N, Fukutomi T, Iwamoto E, Akashi-Tanaka S. Long-term results of T1a, T1b and T1c invasive breast carcinomas in Japanese women: validation of the UICC T1 subgroup classification. Jpn J Clin Oncol. 2002;32:108–9.CrossRef
6.
Zurück zum Zitat Kumar R, Chauhan A, Zhuang H, Chandra P, Achnall M, Alvavi A. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat. 2006;98:267–74.CrossRef Kumar R, Chauhan A, Zhuang H, Chandra P, Achnall M, Alvavi A. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat. 2006;98:267–74.CrossRef
7.
Zurück zum Zitat Bowen SL, Wu Y, Chaudhari AJ, Fu L, Packard NJ, Burkett GW, et al. Initial characterization of a dedicated breast PET/CT scanner during human imaging. J Nucl Med. 2009;50:1401–8.CrossRef Bowen SL, Wu Y, Chaudhari AJ, Fu L, Packard NJ, Burkett GW, et al. Initial characterization of a dedicated breast PET/CT scanner during human imaging. J Nucl Med. 2009;50:1401–8.CrossRef
8.
Zurück zum Zitat Fowler AM. A molecular approach to breast imaging. J Nucl Med. 2014;55:177–80.CrossRef Fowler AM. A molecular approach to breast imaging. J Nucl Med. 2014;55:177–80.CrossRef
9.
Zurück zum Zitat Kalinyak JE, Berg WA, Schilling K, Madsen KS, Narayanan D, Tartar M. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT. Eur J Nucl Med Mol Imaging. 2014;41:260–75.CrossRef Kalinyak JE, Berg WA, Schilling K, Madsen KS, Narayanan D, Tartar M. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT. Eur J Nucl Med Mol Imaging. 2014;41:260–75.CrossRef
10.
Zurück zum Zitat Yamamoto Y, Ozawa Y, Kubouchi K, Nakamura S, Nakajima Y, Inoue T. Comparative analysis of sensitivity of positron emission mammography and whole-body PET in relation to tumor size. Clin Nucl Med. 2015;40:21–5.CrossRef Yamamoto Y, Ozawa Y, Kubouchi K, Nakamura S, Nakajima Y, Inoue T. Comparative analysis of sensitivity of positron emission mammography and whole-body PET in relation to tumor size. Clin Nucl Med. 2015;40:21–5.CrossRef
11.
Zurück zum Zitat Nishimatsu K, Nakamoto Y, Miyake KK, Ishimori T, Kanao S, Toi M, et al. Higher breast cancer conspicuity on dbPET compared to WB-PET/CT. Eur J Radiol. 2017;90:138–45.CrossRef Nishimatsu K, Nakamoto Y, Miyake KK, Ishimori T, Kanao S, Toi M, et al. Higher breast cancer conspicuity on dbPET compared to WB-PET/CT. Eur J Radiol. 2017;90:138–45.CrossRef
12.
Zurück zum Zitat Nakamoto R, Nakamoto Y, Ishimori T, Nishimatsu K, Miyake KK, Kanao S, et al. Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors. Nucl Med Commun. 2017;38:388–95.CrossRef Nakamoto R, Nakamoto Y, Ishimori T, Nishimatsu K, Miyake KK, Kanao S, et al. Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors. Nucl Med Commun. 2017;38:388–95.CrossRef
13.
Zurück zum Zitat Hosono M, Saga T, Ito K, Kumita S, Sasaki M, Senda M, et al. Clinical practice guideline for dedicated breast PET. Ann Nucl Med. 2014;28:597–602.CrossRef Hosono M, Saga T, Ito K, Kumita S, Sasaki M, Senda M, et al. Clinical practice guideline for dedicated breast PET. Ann Nucl Med. 2014;28:597–602.CrossRef
14.
Zurück zum Zitat Miyake KK, Matsumoto K, Inoue M, Nakamoto Y, Kanao S, Oishi T, et al. Performance evaluation of a new dedicated breast PET scanner using NEMA NU4-2008 standards. J Nucl Med. 2014;55:1198–203.CrossRef Miyake KK, Matsumoto K, Inoue M, Nakamoto Y, Kanao S, Oishi T, et al. Performance evaluation of a new dedicated breast PET scanner using NEMA NU4-2008 standards. J Nucl Med. 2014;55:1198–203.CrossRef
15.
Zurück zum Zitat Mitsumoto T, Uno K, Irie M, Wu J, Sasamori H, Tsuchiya Y, et al. The potential of dedicated breast PET with a ring-type scanner—basic evaluation and clinical experience. Radioisotopes. 2018;67:309–19.CrossRef Mitsumoto T, Uno K, Irie M, Wu J, Sasamori H, Tsuchiya Y, et al. The potential of dedicated breast PET with a ring-type scanner—basic evaluation and clinical experience. Radioisotopes. 2018;67:309–19.CrossRef
16.
Zurück zum Zitat Fukukita H, Suzuki K, Matsumoto K, Terauchi T, Daisaki H, Ikari Y, et al. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0. Ann Nucl Med. 2014;28:693–705.CrossRef Fukukita H, Suzuki K, Matsumoto K, Terauchi T, Daisaki H, Ikari Y, et al. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0. Ann Nucl Med. 2014;28:693–705.CrossRef
17.
Zurück zum Zitat MacDonald L, Edwards J, Lewellen T, Rogers J, Kinahan P. Clinical imaging characteristics of the positron emission mammography PEM Flex Solo II. IEEE Nucl Symp Conf Rec. 2008;11:4494–501. MacDonald L, Edwards J, Lewellen T, Rogers J, Kinahan P. Clinical imaging characteristics of the positron emission mammography PEM Flex Solo II. IEEE Nucl Symp Conf Rec. 2008;11:4494–501.
18.
Zurück zum Zitat Raylman RR, Abraham J, Hazard H, Koren C, Filburn S, Schreiman JS, et al. Initial clinical test of a breast PET scanner. J Med Imaging Radiat Oncol. 2011;55:58–64.CrossRef Raylman RR, Abraham J, Hazard H, Koren C, Filburn S, Schreiman JS, et al. Initial clinical test of a breast PET scanner. J Med Imaging Radiat Oncol. 2011;55:58–64.CrossRef
19.
Zurück zum Zitat Qi J, Kuo C, Huesman RH, Klein GJ, Moses WW, Reutter BW. Comparison of rectangular and dual-planar positron emission mammography scanners. IEEE Trans Nucl Sci. 2002;49:2089–96.CrossRef Qi J, Kuo C, Huesman RH, Klein GJ, Moses WW, Reutter BW. Comparison of rectangular and dual-planar positron emission mammography scanners. IEEE Trans Nucl Sci. 2002;49:2089–96.CrossRef
20.
Zurück zum Zitat Yamakawa Y, Kitamura K. Attenuation correction using level set method for application specific PET scanners. In: Nuclear science symposium and medical imaging conference (NSS/MIC) IEE. pp 3130–2; 2011. Yamakawa Y, Kitamura K. Attenuation correction using level set method for application specific PET scanners. In: Nuclear science symposium and medical imaging conference (NSS/MIC) IEE. pp 3130–2; 2011.
21.
Zurück zum Zitat Bailey DL, Meikle SR. A convolution-subtraction scatter correction method for 3D PET. Phys Med Biol. 1994;39:411–24.CrossRef Bailey DL, Meikle SR. A convolution-subtraction scatter correction method for 3D PET. Phys Med Biol. 1994;39:411–24.CrossRef
22.
Zurück zum Zitat Park HH, Shin JY, Lee JY, Jin GH, Kim HS, Lyu KY, et al. Discussion on the alteration of 18F-FDG uptake by the breast according to the menstrual cycle in PET imaging. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:2469–72.PubMed Park HH, Shin JY, Lee JY, Jin GH, Kim HS, Lyu KY, et al. Discussion on the alteration of 18F-FDG uptake by the breast according to the menstrual cycle in PET imaging. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:2469–72.PubMed
23.
Zurück zum Zitat Leithner D, Baltzer PA, Magometschnigg HF, et al. Quantitative assessment of breast parenchymal uptake on 18F-FDG PET/CT: correlation with age, background parenchymal enhancement, and amount of fibroglandular tissue on MRI. J Nucl Med. 2016;57:1518–22.CrossRef Leithner D, Baltzer PA, Magometschnigg HF, et al. Quantitative assessment of breast parenchymal uptake on 18F-FDG PET/CT: correlation with age, background parenchymal enhancement, and amount of fibroglandular tissue on MRI. J Nucl Med. 2016;57:1518–22.CrossRef
24.
Zurück zum Zitat Satoh Y, Motosugi U, Omiya Y, Onishi H. Unexpected abnormal uptake in the breasts at dedicated breast PET: incidentally detected small cancers or nonmalignant features? AJR Am J Roentgenol. 2019;212:443–9.CrossRef Satoh Y, Motosugi U, Omiya Y, Onishi H. Unexpected abnormal uptake in the breasts at dedicated breast PET: incidentally detected small cancers or nonmalignant features? AJR Am J Roentgenol. 2019;212:443–9.CrossRef
25.
Zurück zum Zitat Phantom test procedure for whole body PET imaging using 18F–FDG, 3rd ed. Japanese Society of Nuclear Medicine, PET Nuclear Medicine Committee; 2017. Phantom test procedure for whole body PET imaging using 18F–FDG, 3rd ed. Japanese Society of Nuclear Medicine, PET Nuclear Medicine Committee; 2017.
26.
Zurück zum Zitat Yamamoto Y, Tasaki Y, Kuwada Y, Ozawa Y, Inoue T. A preliminary report of breast cancer screening by positron emission mammography. Ann Nucl Med. 2016;30:130–7.CrossRef Yamamoto Y, Tasaki Y, Kuwada Y, Ozawa Y, Inoue T. A preliminary report of breast cancer screening by positron emission mammography. Ann Nucl Med. 2016;30:130–7.CrossRef
27.
Zurück zum Zitat García Hernández T, Vicedo González A, Ferrer Rebolleda J, Sánchez Jurado R, Roselló Ferrando J, Brualla González L, et al. Performance evaluation of a high resolution dedicated breast PET scanner. Med Phys. 2016;43:2261–72.CrossRef García Hernández T, Vicedo González A, Ferrer Rebolleda J, Sánchez Jurado R, Roselló Ferrando J, Brualla González L, et al. Performance evaluation of a high resolution dedicated breast PET scanner. Med Phys. 2016;43:2261–72.CrossRef
28.
Zurück zum Zitat Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. Eur J Nucl Med Mol Imaging. 2013;40:1507–15.CrossRef Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. Eur J Nucl Med Mol Imaging. 2013;40:1507–15.CrossRef
Metadaten
Titel
Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study
verfasst von
Yoko Satoh
Utaroh Motosugi
Masamichi Imai
Hiroshi Onishi
Publikationsdatum
25.11.2019
Verlag
Springer Singapore
Erschienen in
Annals of Nuclear Medicine / Ausgabe 2/2020
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-019-01422-0

Weitere Artikel der Ausgabe 2/2020

Annals of Nuclear Medicine 2/2020 Zur Ausgabe